Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma

NCT03367715 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

MGMT-unmethylated Glioblastoma (GBM)
GBM

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab
RADIATION: Radiation Therapy (RT)

Sponsor

NYU Langone Health